The conversation was in the last proactive video at the 3:40 mark. Nader was giving an update on CD20 Critical in the USA. He clearly said that the FDA said we could use meta analysis and then he stated that he will talk to the Brazilian folks and Anvisa to see if we can have meta analysis in Brazil also. Talked about only needing 15-20 patients in our critical trial in Brazil along with our 62 patients in our CD15 trial sub group.

This whole meta analysis is intriguing to say the least… maybe something quick becomes of this?

Here is the proactive video…


https://youtu.be/GmpJ639gjnk